What does Rusfertide (Mimrylo) do in plain English—and how does it work inside your body?
Rusfertide is an FDA-regulated FDA Prescription Therapeutic Agent (RxNorm RxCUI 2751601). Mechanistically, 12.1 Mechanism of Action Rusfertide is a mimetic of the endogenous hormone hepcidin that blocks the iron transporter ferroportin. Inhibition of ferroportin by rusfertide reduces availability of iron for production of red blood cells resulting in lower hematocrit levels. [1][2].
When your doctor writes a prescription for Rusfertide (RxNorm RxCUI 2751601, also dispensed under brand names including Mimrylo), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, 12.1 Mechanism of Action Rusfertide is a mimetic of the endogenous hormone hepcidin that blocks the iron transporter ferroportin. Inhibition of ferroportin by rusfertide reduces availability of iron for production of red blood cells resulting in lower hematocrit levels. [2].
Across real-world patient logs on dotMD (80% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Rusfertide tablet bottle and confirm with your pharmacist that it matches your prescribed strength (Kit, 19 mg, 108 mg).